Raw Data Investigation of the Trends and Associated Factors of Ovarian Cancer in Indonesia: A Systematic Analysis of the Global Burden of Disease Study 1990–2019

Ovarian cancer is one of the most lethal gynecological cancers. Despite diagnosis and treatment advances, survival rates have not increased over the past 30 years. This study estimated and reported the global burden of ovarian cancer during the past 30 years to inform preventative and control strategies. We examined ovarian cancer incidence, mortality, and disability-adjusted life years (DALYs) using age-standardized rates from the Global Burden of Disease, Injuries, and Risk Factors Study 2019. Elevated fasting plasma glucose, occupational asbestos exposure, and high body mass index were associated with death. Data are presented as averages with 95 % uncertainty intervals (UIs).Indonesia had 2961 (2077–5708) ovarian cancer cases in 2019, with 1841 (1371–3407) deaths and 65 692 (47 198–124 857) DALYs. The burden increased by 256.1 % (215.1–245.7 %) for new cases, 232.1 % (182.3 to 241.9 %) for fatalities, and 208.8 % (169.1 to 205.3 %) for DALYs. The age-standardized rate also increased from 1990 to 2019. Ovarian cancer burden increased with age but dropped in the 65+ year age group. According to the sociodemographic index, the gross domestic product per capita and the number of obstetricians and oncologic gynecologists in provinces showed different trends.<b> </b>Indonesian ovarian cancer rates are rising despite gynecologic oncologists in 25 of 34 provinces. These findings will help policymakers and healthcare providers identify ovarian cancer prevention and control gaps.